| Daniel Abou-semaan, | |
|
11 Bluff Ln, Saint Albans, VT 05478-3303 | |
| (954) 790-9010 | |
| Not Available |
| Full Name | Daniel Abou-semaan |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 11 Bluff Ln, Saint Albans, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609598226 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | At Home By Enhance Therapies Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124603246 PECOS PAC ID: 4183033210 Enrollment ID: O20220328002556 |
News Archive
Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are all characterized by clumped, misfolded proteins and inflammation in the brain. In more than 90 percent of cases, physicians and scientists do not know what causes these processes to occur.
Scientists have found that levels of the amino acid homocysteine may be high in people destined for a heart attack or stroke, and some studies in the past have linked homocysteine to an increased risk of heart disease.
The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the Perelman School of Medicine, University of Pennsylvania.
Nephros, Inc. and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management's guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Abou-semaan, 11 Bluff Ln, Saint Albans, VT 05478-3303 Ph: (954) 790-9010 | Daniel Abou-semaan, 11 Bluff Ln, Saint Albans, VT 05478-3303 Ph: (954) 790-9010 |
News Archive
Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are all characterized by clumped, misfolded proteins and inflammation in the brain. In more than 90 percent of cases, physicians and scientists do not know what causes these processes to occur.
Scientists have found that levels of the amino acid homocysteine may be high in people destined for a heart attack or stroke, and some studies in the past have linked homocysteine to an increased risk of heart disease.
The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the Perelman School of Medicine, University of Pennsylvania.
Nephros, Inc. and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management's guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.
› Verified 2 days ago
Tasia Carlyle, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Jennifer Ann Mcavey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-1064 Fax: 802-524-1025 | |
Erin Aimee Medick, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-1064 Fax: 802-524-1025 | |
Caitlin Marie Rollet, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans Healthcare And Rehabilitation Center, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Katherine J Moody, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Fairfax Rd, Saint Albans, VT 05478 Phone: 802-752-1600 | |
Brenda Lee Wardner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Melissa Dawn Rafferty, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 804-524-1064 Fax: 802-524-1025 |